About the Company
We do not have any company description for OptimizeRx Corp at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on OptimizeRx Corp
All You Need to Know About OptimizeRx (OPRX) Rating Upgrade to Strong Buy
OptimizeRx Corp. (OPRX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, ...
Best Momentum Stock to Buy for August 21st
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 21st: ...
OptimizeRx Corp. Announces Conference Call to Discuss Fiscal 2024 ...
OptimizeRx Corp. will host a conference call on March 12, 2025, at 8:30 a.m. Eastern Time to discuss its fiscal year 2024 financial results and fourth-quarter results for the period ending ...
OptimizeRx Stock Rallies 22% After-Hours Thanks To Q2 Earnings Push
OptimizeRx's stock jumped 22.66% after hours following strong Q2 earnings that beat expectations and lifted the share price from $12.84 to $15.75.
OptimizeRx Corp. Appoints Steve Silvestro to Board of Directors
Quiver AI Summary OptimizeRx Corp. has appointed Steve Silvestro, currently the Chief Executive Officer, to its Board of Directors effective June 20, 2025.
OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive ...
WALTHAM, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach ...
Here’s Why Artisan Partners Exited its Position in OptimizeRx ...
On November 11, 2022, OptimizeRx Corporation (NASDAQ:OPRX) stock closed at $22.01 per share. One-month return of OptimizeRx Corporation (NASDAQ:OPRX) was 42.46% and its shares lost 72.52% of their ...
OptimizeRx Announces Agreement with a Top Pharmaceutical Manufacturer ...
ROCHESTER, Mich., July 14, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and ...
Similar Companies
Loading the latest forecasts...